Reach Us +1 702 553-3066
Antonio Avallone | OMICS International
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Antonio Avallone


Sustained Efficacy of Cetuximab after Therapy Discontinuation in a Patient with Advanced Colorectal Cancer

In pivotal phase II and III studies, the targeting monoclonal antibody cetuximab has been shown to improve the efficacy of standard chemotherapy regimens used in first-line treatment of metastatic colorectal cancer. Safety data analyses from these studies indicate that cetuximab plus chemotherapy appears to be associated with a higher incidence of ... Read More»

Gerardo Rosati, Enrico Scarano, Antonio Avallone and Domenico Bilancia

Case Report: J Carcinogene Mutagene 2014, S10 - 004

DOI: 10.4172/2157-2518.S10-004

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article